Valuation: DexCom, Inc.

Market Cap 27.07B 140B 23.73B 21.87B 20.48B 38.4B 2,553B 39.2B 263B 102B 1,262B 102B 99.41B 4,375B P/E 2026 *
28.7x
P/E 2027 * 24x
Enterprise Value 26.66B 138B 23.38B 21.55B 20.17B 37.83B 2,515B 38.61B 259B 100B 1,243B 100B 97.92B 4,310B EV / Sales 2026 *
5.1x
EV / Sales 2027 * 4.43x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day+1.82%
1 week-3.06%
Current month-1.89%
1 month+2.39%
3 months+10.81%
6 months-2.54%
Current year-2.80%
1 week 7.11
Extreme 7.11
7.59
1 month 7.11
Extreme 7.11
8.14
Current year 5.75
Extreme 5.75
8.14
1 year 5.75
Extreme 5.75
10.06
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%-3.06% - - 27.07B
+0.94%+6.46%-29.96%-12.68% 164B
+1.48%+2.07%-5.86%-7.08% 104B
-0.29%+5.26%-4.44%+51.57% 55.67B
-2.09%-6.13%+50.84%+54.81% 52.92B
+3.00%+8.29%-8.74%-39.62% 42.96B
+2.91%+8.15% - - 32.87B
+1.24%+6.98%+60.30%-5.01% 24.79B
+2.41%+6.45%-9.68%-0.53% 21.02B
+0.84%-0.56%-18.30%-0.34% 20.18B
Average +1.23%+3.72%+4.27%+5.14% 57.56B
Weighted average by Cap. +1.01%+4.04%-5.21%+2.30%

Financials

2026 *2027 *
Net sales 5.22B 26.99B 4.58B 4.22B 3.95B 7.41B 493B 7.57B 50.75B 19.64B 244B 19.62B 19.19B 845B 5.83B 30.11B 5.11B 4.71B 4.41B 8.27B 550B 8.44B 56.63B 21.91B 272B 21.89B 21.41B 942B
Net income 963M 4.97B 844M 778M 728M 1.37B 90.8B 1.39B 9.35B 3.62B 44.88B 3.61B 3.54B 156B 1.16B 5.98B 1.02B 936M 876M 1.64B 109B 1.68B 11.25B 4.35B 53.97B 4.35B 4.25B 187B
Net Debt -405M -2.09B -355M -327M -306M -575M -38.21B -587M -3.93B -1.52B -18.88B -1.52B -1.49B -65.48B -1.21B -6.26B -1.06B -979M -917M -1.72B -114B -1.75B -11.77B -4.55B -56.47B -4.55B -4.45B -196B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-06-24 R$7.280 +1.82% 110
26-06-23 R$7.150 +0.56% 105
26-06-22 R$7.110 -5.33% 213
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
70.14USD
Average target price
85.24USD
Spread / Average Target
+21.53%

Quarterly revenue - Rate of surprise